Related Experiment Video
Updated: Jul 4, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports
David P Gallagher1, Jennifer Kieran, Gerard Sheehan
1Department of 1Infectious Diseases, Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland. davgallagher@gmail.com
Abstract:
We describe 2 cases of symptomatic ventricular tachycardia associated with prolonged QT interval. Both patients were infected with the human immunodeficiency virus and were receiving treatment with ritonavir-boosted atazanavir and methadone. Discontinuation of atazanavir in both cases resulted in a reduction in the QT interval and cessation of arrhythmia. We concluded that atazanavir contributed to prolonged corrected QT interval and subsequent ventricular tachycardia.
Related Concept Videos
Myocarditis III: Medical Management
Dysrhythmias II: Classification of Tachyarrhythmias
Antiviral Nucleoside Inhibitors
Drug Toxicity: Risk factors
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
